NASDAQ: CDTX       Cidara Thera
Last Price Today's Change   Day's Range   Trading Volume
3.62   +0.04 (1.12%)  3.37 - 3.68  158,300


Avg Volume (4 weeks):275,163
4 Weeks Range:2.67 - 3.75
4 Weeks Price Volatility (%):
52 Weeks Range:1.223 - 4.44
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Cidara Therapeutics Inc functions in the healthcare sector based in the United States. Its business involves the development of novel anti-infectives for the treatment of serious infections, especially caused due to fungus. The company's main drug constitutes echinocandins antifungals in the form of CD101IV and CD101 topical. CD101 IV is a long-acting therapy for the treatment and prevention of serious, invasive fungal infections. CD101 topical, its second product candidate, is being developed for the treatment of vulvovaginal candidiasis. In addition, Cidara has developed a proprietary immunotherapy technology platform, Cloudbreak, which is used to create compounds designed to direct a patient's immune cells to attack and eliminate pathogens that cause infectious diseases.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

4779  3343  551  179 

Top 10 Active Counters
 GE 6.57-0.21 
 NLY 6.16-0.18 
 SPY 304.32+1.35 
 BAC 24.12-0.74 
 ADAP 11.07+6.21 
 MRO 5.34-0.36 
 F 5.71-0.14 
 XLF 23.41-0.27 
 SQQQ 9.43-0.40 
 NERV 3.71-9.76 
Partners & Brokers